MIB-1 labeling index, Ki-67, is an indicator of invasive intraductal papillary mucinous neoplasm

被引:5
|
作者
Shimura, Tatsuo [1 ]
Kofunato, Yasuhide [2 ]
Okada, Ryo [2 ]
Yashima, Rei [2 ]
Okada, Koji [3 ]
Araki, Kenichiro [3 ]
Hosouchi, Yasuo [4 ]
Kuwano, Hiroyuki [3 ]
Takenoshita, Seiichi [2 ]
机构
[1] Fukushima Med Univ, Dept Canc Biol & Elect, 1 Hikarigaoka, Fukushima 9601295, Japan
[2] Fukushima Med Univ, Dept Organ Regulatory Surg, Fukushima 9601295, Japan
[3] Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, Gunma 3718511, Japan
[4] Gunma Prefecture Saiseikai Maebashi Hosp, Dept Surg & Laparoscop Surg, Maebashi, Gunma 3710821, Japan
关键词
IPMN; MIB-1; Ki-67; invasive IPMN; mural nodule;
D O I
10.3892/mco.2016.908
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Despite strict criteria for the observation of intraductal papillary mucinous neoplasm (IPMN), it remains difficult to distinguish invasive IPMN from non-invasive IPMN. The aim of the present study was to identify an indicator of invasive IPMN. The present study retrospectively evaluated 53 patients (28 with non-invasive and 25 with invasive IPMN) who underwent resection of IPMN, and examined the usefulness of the MIB-1 labeling index as an indicator of invasive IPMN. The MIB-1 labeling indexes in patients with invasive IPMN were significantly higher compared with those with non-invasive IPMN (P<0.001). A receiver operating characteristic curve revealed that the area under the curve was 0.822. These results suggested that a cut-off level for the MIB-1 labeling index should be set to 15.5% to distinguish invasive from non-invasive IPMN. A multivariate analysis using a logistic regression model revealed the MIB-1 labeling index (hazard ratio, 18.692; 95% confidential interval, 4.171-83.760; P<0.001) and the existence of mural nodules (hazard ratio, 6.187, 95% confidential interval, 1.039-36.861; P=0.045) were predictive factors for invasive IPMN. However, no statistically significant differences were observed between patients with a lower MIB-1 labeling index and patients with a higher MIB-1 labeling index (P=0.798). The MIB-1 labeling index must be considered as a candidate for the classification of IPMN.
引用
收藏
页码:317 / 322
页数:6
相关论文
共 50 条
  • [31] Gemcitabine in Patients With Intraductal Papillary Mucinous Neoplasm With an Associated Invasive Carcinoma of the Pancreas
    Otsuka, Taiga
    Morizane, Chigusa
    Nara, Satoshi
    Ueno, Hideki
    Kondo, Shunsuke
    Shimada, Kazuaki
    Kosuge, Tomoo
    Ikeda, Masafumi
    Hiraoka, Nobuyoshi
    Okusaka, Takuji
    PANCREAS, 2013, 42 (05) : 889 - 892
  • [32] Immunohistochemical analyses of E-cadherin, β-catenin, CD44s, and CD44v6 expressions, and Ki-67 labeling index in intraductal papillary mucinous neoplasms of the pancreas and associated invasive carcinomas
    Okimura, Akira
    Hirano, Hiroshi
    Nishigami, Takashi
    Ueyama, Shigemitsu
    Tachibana, Shiro
    Fukuda, Yoshikazu
    Yamanegi, Koji
    Ohyama, Hideki
    Terada, Nobuyuki
    Nakasho, Keiji
    MEDICAL MOLECULAR MORPHOLOGY, 2009, 42 (04) : 222 - 229
  • [33] Expression of Ki-67 antigen using monoclonal antibody MIB-1 in children with post-streptococcal glomerulonephritis
    Chung, WY
    Kim, YJ
    PEDIATRIC NEPHROLOGY, 2000, 14 (05) : 389 - 392
  • [34] Immunohistochemical analyses of E-cadherin, β-catenin, CD44s, and CD44v6 expressions, and Ki-67 labeling index in intraductal papillary mucinous neoplasms of the pancreas and associated invasive carcinomas
    Akira Okimura
    Hiroshi Hirano
    Takashi Nishigami
    Shigemitsu Ueyama
    Shiro Tachibana
    Yoshikazu Fukuda
    Koji Yamanegi
    Hideki Ohyama
    Nobuyuki Terada
    Keiji Nakasho
    Medical Molecular Morphology, 2009, 42 : 222 - 229
  • [35] Successful treatment with conversion surgery following chemoradiotherapy for unresectable invasive intraductal papillary mucinous neoplasm
    Kameyama, Shinichiro
    Motonari, Haruka
    Ishimine, Tomonari
    Isa, Tsutomu
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2020, 13 (04) : 579 - 584
  • [36] Long-term survival after resection of invasive pancreatic intraductal papillary mucinous neoplasm
    Addeo, Pietro
    Canali, Giulia
    Paul, Chloe
    de Mathelin, Pierre
    Averous, Gerlinde
    Bachellier, Philippe
    LANGENBECKS ARCHIVES OF SURGERY, 2024, 409 (01)
  • [37] Clinical significance of Ki-67 labeling index in pituitary macroadenoma
    Paek, KI
    Kim, SH
    Song, SH
    Choi, SW
    Koh, HS
    Youm, JY
    Kim, Y
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2005, 20 (03) : 489 - 494
  • [38] KI-67 ANTIBODY LABELING INDEX IN COLORECTAL-CARCINOMA
    SUZUKI, H
    MATSUMOTO, K
    TERABE, M
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 1992, 15 (04) : 317 - 320
  • [39] The clinical significance of MIB-1 labeling index in pituitary adenomas
    Chacko, Geeta
    Chacko, Ari G.
    Kovacs, Kalman
    Scheithauer, Bernd W.
    Mani, Sunithi
    Muliyil, J. P.
    Seshadri, M. S.
    PITUITARY, 2010, 13 (04) : 337 - 344
  • [40] Prognostic significance of the MIB-1 labeling index for patient with craniopharyngioma
    Nishi, T
    Kuratsu, JI
    Takeshima, H
    Saito, Y
    Kochi, M
    Ushio, Y
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 1999, 3 (02) : 157 - 161